B Bilgin Global Mod Global Mod 25 Nis 2022 #1 Glenmark to launch fixed‐dose drug for type-2 Diabetes in India Glenmark to launch Teneligliptin + Pioglitazone fixed‐dose drug for type-2 Diabetes in India
Glenmark to launch fixed‐dose drug for type-2 Diabetes in India Glenmark to launch Teneligliptin + Pioglitazone fixed‐dose drug for type-2 Diabetes in India